NMDA receptor antagonist 4
NMDA receptor antagonist 4 (IIc) is a uncompetitive, voltage-dependent, orally active NMDAR blocker, with an IC50 of 1.93 μM. NMDA receptor antagonist 4 shows a positive predicted blood-brain-barrier (BBB) permeability, and can be studied in Alzheimer's disease[1].
Product Specifications
CAS Number
[1607589-56-9]
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/nmda-receptor-antagonist-4.html
Purity
99.64
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
NC12CC3C4=CC=CC=C4C(CC(F)(C2)C3)C1
Molecular Formula
C15H18FN
Molecular Weight
231.31
References & Citations
[1]Andreea L. Turcu, et al. Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease. Eur J Med Chem. 2022 Apr 8;236:114354.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15370896 1 Vial
Lentiviral human TMEM260 sgRNA gene knockout kit - Lentiviral human TMEM260 sgRNA gene knockout kit (25)
Ask
View Details 
